Category Archives: Off Patent

US FDA publishes list of off-patent, off-exclusivity branded drugs without approved generics

Silver Spring, Maryland,  Pharmabiz | June 29, 2017 Thursday, June 29, 2017 The US Food and Drug Administration is taking two new, important steps to increase competition in the market for prescription drugs and facilitate entry of lower-cost alternatives. The agency … Continue reading

Posted in Generic competition, Off Patent, Uncategorized | Leave a comment